Search for: "Merck and Co," Results 381 - 400 of 1,277
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Nov 2012, 12:38 pm by Schachtman
  As I noted in “Confusion Over Causation in Texas” (Aug. 27, 2011), the Texas Supreme Court managed to confuse general and specific causation concepts in its decision in Merck & Co. v. [read post]
21 Nov 2012, 5:00 am by Bexis
Merck & Co.,, No. 267003, 2006 WL 1628516, at *3 (Mich. [read post]
9 Nov 2012, 6:54 am
Fosamax ONJ Claims There are Fosamax jaw necrosis lawsuits that are pending against Merck & Co. over their oral bisphosphonate medication. [read post]
5 Nov 2012, 11:30 am
Zambri, founding member and partner The AP (11/2) reported Merck & Co. [read post]
17 Oct 2012, 9:46 pm
A little over a year after her death, the estate of Shirley Boles has reached a confidential damage award agreement with pharmaceutical giant Merck & Co. over injuries she sustained from the drug Fosamax. [read post]
28 Sep 2012, 11:15 am by Todd M. Nosher
Earlier this month, we reported that Merck & Co. had filed a petition for a Writ of Certiorari seeking to challenge the Third Circuit’s decision in In re K-Dur Antitrust Litig. holding that reverse payments are prima facie evidence of an antitrust violation. [read post]
13 Sep 2012, 4:26 pm by Brad Pauley
  On its own motion, the Court stayed further briefing in this matter pending action by the United States Supreme Court in Merck & Co. v. [read post]
6 Sep 2012, 11:00 am by Tom Lamb
Merck & Co., Inc., 06 Civ. 9455 (JFK), case is set for a new jury trial on damages before United States District Court Judge Joseph F. [read post]
6 Sep 2012, 11:00 am by Tom Lamb
Merck & Co., Inc., 06 Civ. 9455 (JFK), case is set for a new jury trial on damages before United States District Court Judge Joseph F. [read post]
4 Sep 2012, 7:04 am by Todd M. Nosher
As expected, Merck & Co. recently filed its Petition for a Writ of Certiorari, citing this split of circuit authority as the compelling factor favoring a review by the Supreme Court. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
  This long-running litigation involves a challenge by direct purchasers of K-DUR (potassium chloride) Extended-release Tablets who allege that Merck & Co., Inc. [read post]
27 Aug 2012, 6:48 am by Marissa Miller
On Friday a cert. petition was filed in Merck & Co., Inc., v. [read post]
24 Aug 2012, 7:46 pm by Lyle Denniston
   In the high-profile “K-Dur” case of Merck & Co., Inc., v. [read post]
22 Aug 2012, 6:09 am
Drug companies including Pfizer, Merck & Co. and Bristol Myers-Squibb Co. are squeezed by rising research costs, the weak global economy and pressure from Europe, China and elsewhere to reduce drug prices. [read post]
10 Aug 2012, 7:52 pm by Linda Moss
R&D on several CGRP blockers, including one by Merck & Co., was scrapped when it was discovered that the drug damaged the liver, The Journal reported. [read post]